Merck ($MRK) has gone to the ends of the earth to develop new antibodies. Now it's headed into space. Merck Research Laboratories is turning to the International Space Station to see whether a microgravity environment can help it better study antibodies. Investigators have gone into space before to use the environment to gain higher resolution of antibody structures in the complex engineering work they do. Story